Stephens & Co. Reiterates Overweight on Akoya Biosciences, Maintains $16 Price Target
Stephens & Co. analyst Mason Carrico reiterates Akoya Biosciences (NASDAQ:AKYA) with a Overweight and maintains $16 price target.
Earnings Scheduled For March 6, 2023
Companies Reporting Before The Bell
• Passage Bio (NASDAQ:PASG) is estimated to report earnings for its fourth quarter.
Why Party City Holdco Shares Tumbled Over 40%; Here Are 98 Biggest Movers From Yesterday
Gainers
Unique Fabricating, Inc. (NYSE: UFAB) jumped 56.3% to close at $0.8205 on Tuesday. Unique Fabricating posted a Q3 loss of $0.90 per share after the closing bell on Tuesday.
Why TaskUs Shares Are Trading Higher By 37%? Here Are 77 Stocks Moving In Tuesday’s Mid-Day Session
Gainers
IceCure Medical Ltd (NASDAQ: ICCM) shares jumped 39.4% to $1.4529 after the company announced a payment assignment from the Centers for Medicare & Medicaid Services for the ProSense breast cancer cryoablation procedures.
Earnings Scheduled For November 7, 2022
Companies Reporting Before The Bell
• NAPCO Security Techs (NASDAQ:NSSC) is expected to report quarterly earnings at $0.13 per share on revenue of $36.34 million.
Preview: Akoya Biosciences’s Earnings
Akoya Biosciences (NASDAQ:AKYA) is set to give its latest quarterly earnings report on Monday, 2022-11-07. Here's what investors need to know before the announcement.
Analysts estimate that Akoya Biosciences will report an earnings per share (EPS) of $-0.43.
Stephen Initiates This Spatial Biology Player Citing Strong Competitive Position
Stephens started coverage on Akoya Biosciences Inc (NASDAQ:AKYA) with an Overweight rating and price target of $16. The analyst views Akoya…
Akoya Biosciences’s Return On Capital Employed Insights
Akoya Biosciences (NASDAQ:AKYA) brought in sales totaling $17.89 million during Q2 according to data provided by Benzinga Pro. However, earnings decreased 6.68%, resulting in a loss of $17.50 million.